Jennie Lee

Jennie Lee has a diverse and extensive work experience in the pharmaceutical industry. Jennie is currently working as the Associate Director of Analytical Development and Quality Control at Leap Therapeutics since August 2021. Prior to this, they held the position of Sr Manager of Analytical Development and Quality Control at the same company from May 2021 to October 2023.

Before joining Leap Therapeutics, Jennie worked at Sanofi as a QC Manager - QA Technical Services from January 2020 to May 2021. Jennie also has experience working at Moderna as a Senior QC Specialist (Analytical Method Transfers) from February 2019 to January 2020, and at Brammer Bio as a Senior Scientist (Analytical QC) from September 2018 to February 2019.

Jennie's early career started at Genzyme Corp in 2006, where they held various roles including Principal QC Analyst (Methods Validation) from March 2017 to September 2018, Senior QC Analyst (Methods Validation) from October 2013 to March 2017, Senior QC Analyst (Operations) from September 2009 to September 2013, and QC Analyst II from February 2006 to September 2009.

Jennie'sinitial work experience can be traced back to Life Technologies, where they worked as a Senior Inspector from an unknown start date to 2006. Overall, Jennie Lee has gained significant expertise and knowledge in analytical development, quality control, and pharmaceutical operations throughout their career.

Jennie Lee attended Boston University where they pursued a Bachelor of Science degree in Biochemistry and Molecular Biology. No further education history is provided.